Global At-Home Cancer Testing Kits Market Report Segmented by Sample Type (Blood, Urine, or Saliva); By Distribution Channel (Retail Pharmacies, Online Pharmacies, Direct-to-Consumer Platforms); and Region - Size, Share, Growth Analysis | Forecast (2023 2030)

Market Size and Overview:

The Global At-Home Cancer Testing Kits Market reached an estimated valuation of USD 6.2 billion in 2022 and is anticipated to achieve a value of USD 9.23 billion by the conclusion of 2030, maintaining a consistent Compound Annual Growth Rate (CAGR) of 5.1% throughout the forecast period spanning from 2023 to 2030.

Diagnostic tools designed for at-home cancer testing empower individuals to perform rapid tests and obtain immediate results within the confines of their residences. These tools play a pivotal role in the early detection and screening of cancer, often before the manifestation of noticeable symptoms. Depending on the nature of the test, individuals may be required to collect samples such as urine, feces, saliva, a vaginal swab, or a blood sample. Some tests necessitate the dispatch of samples to a laboratory for examination, while others can be entirely completed at home.

As per information provided by the World Health Organization (WHO), cancer stands as the primary cause of mortality, contributing to over 10 million deaths in 2020, with lung, colorectal, and liver cancers emerging as the most prevalent types. Cancer testing kits facilitate swift detection, enabling patients to initiate early therapeutic interventions to mitigate the impact of the disease. Utilizing various immunoassays and biochemical assay-based methodologies, these kits identify the presence of tumor cells and tumor markers in the bloodstream.

The trend of individuals opting for self-diagnosis within the comfort of their homes has led to a surge in the popularity of home test kits in recent years. The detection of the onset of cancer relies on markers such as the Human Papillomavirus (HPV) and biological samples like blood and feces. Throughout the forecast period, major corporations are expected to initiate a growing number of research and development initiatives, aiming to expedite the diagnostic process and integrate software solutions into cancer test kits.

Global At-Home Cancer Testing Kits Market Drivers:

Convenience, cost, and timeliness of these goods are further market factors for at-home cancer testing kits:

For individuals facing challenges in accessing medical facilities or those valuing the privacy of home testing, at-home cancer testing kits offer convenience and accessibility. These kits empower individuals to conduct tests and collect samples within the comfort of their residences. Particularly beneficial for individuals residing in remote areas, experiencing limited mobility, or having busy schedules hindering healthcare institution visits, these kits eliminate the necessity for travel and reduce waiting times associated with clinic appointments. Moreover, they afford discretion and privacy, allowing individuals to control and safeguard the confidentiality of their medical information.

Through at-home cancer testing kits, early diagnosis of cancer is essential for successful treatment and better patient outcomes:

At-home cancer testing kits often include user-friendly materials and clear instructions, facilitating the straightforward collection of samples and accurate completion of tests. To address any inquiries or concerns arising during the testing process, many kits also provide online or telephone support.

Crucially, early cancer diagnosis is pivotal for effective treatment and improved patient outcomes through at-home cancer testing kits. These kits enable individuals to collect samples, such as blood, urine, or stool, in the comfort of their homes and submit them to a laboratory for examination. The samples undergo analysis for specific biomarkers or genetic alterations associated with various cancer types. Individuals are advised to consult with healthcare professionals for further assessment and treatment if anomalies are detected. By offering accessible and cost-effective means for patients to assess their risk of specific cancer types or monitor their current status, at-home cancer testing kits contribute to early cancer diagnosis.

These kits are particularly valuable for individuals lacking access to conventional medical care or facing barriers such as stigma, fear, or lack of awareness. Certain assays included in these kits can detect chemicals released by cancer cells even before symptoms manifest, such as detecting blood in the stool or DNA alterations in saliva. Some kits also facilitate access to a doctor's appointment or a licensed laboratory for additional testing.

Global At-Home Cancer Testing Kits Market Challenges:

At-Home Cancer Testing Kits' market revenue growth is mostly constrained by the high cost of diagnostic kits:

One of the primary challenges impeding the market's revenue growth is the elevated cost associated with diagnostic kits. The initial expense of cancer screening kits designed for home use poses a significant barrier, potentially dissuading patients from embracing these kits. The pricing of Cancer Screening Test kits varies from USD 30 to USD 90, with subscription discounts available, imposing a considerable financial burden on the healthcare system. Over the past decade, medical costs have surged significantly, witnessing a substantial 27% increase in 2020. Projections from the National Cancer Institute indicate that the national economic impact of cancer-related medical expenses reached approximately USD 150 billion. Additional factors projected to hamper market revenue growth during the forecasted period include the potential for false positive outcomes from cancer test kits and technological challenges associated with sample storage and collection.

COVID-19 Impact on Global At-Home Cancer Testing Kits Market:

The COVID-19 pandemic has had a profound effect on the at-home cancer testing market. Various facets of the at-home cancer testing industry, including manufacturing, processing, supply, distribution, import, export, and more, have experienced disruptions due to the implementation of lockdown measures aimed at curbing the virus's spread. Despite these challenges, there are certain opportunities emerging in the at-home cancer testing market, such as reduced demand, decreased manufacturing and processing, lowered supply and distribution, decreased pricing, disruptions to import and export, and an uncertain future. Social distancing, a key measure in reducing COVID-19 cases and preventing virus transmission, has led to a surge in popularity for stool-based screening tests conducted at home, particularly as hospitals curtailed non-emergency operations to conserve resources and limit virus spread. Some manufacturers have introduced home colon cancer testing kits in response to the need for at-home testing, resulting in a decline in patient visits to healthcare facilities for cancer testing.

Global At-Home Cancer Testing Kits Market Recent developments:

LifeCell, a provider of stem cell and tissue storage services, announced the launch of the first at-home self-test kit designed for screening the presence of the Human Papillomavirus (HPV).

Global At-Home Cancer Testing Kits Market Segmentation:

By Sample Type:

• Blood
• Urine
• Saliva

Among the various sample types, blood-based testing kits are experiencing the most significant expansion within the market for at-home cancer testing kits. This category, utilizing blood samples, is frequently employed in cancer screening diagnostics. The appeal of blood-based testing kits lies in their capacity to identify specific biomarkers or genetic anomalies associated with cancer. Leveraging advanced technologies such as DNA sequencing or immunoassays, these kits demonstrate precision and practicality in detecting blood-based cancer indicators.

Owing to their accuracy, convenience, and ability to identify a range of cancers, blood-based testing kits are gaining increasing popularity. Urine-based testing kits constitute the largest segment in the at-home cancer screening tools market. These kits analyze urine samples to determine the presence of certain cancer biomarkers or metabolites. Conducting tests with urine-based kits can be done at home without specialized equipment, offering a non-invasive and user-friendly option. These kits prove particularly valuable for the early detection of kidney and bladder cancers. The widespread availability, simplicity, and cost-effectiveness contribute to the dominance of urine-based testing kits in the market.

By Distribution Channel:

• Retail Pharmacies
• Online Pharmacies
• Direct-to-Consumer Platforms

Currently, the retail pharmacy segment holds the dominant position in the market. The prevalence of retail pharmacies, facilitating easy access to at-home cancer testing kits for consumers, is a key contributing factor to this dominance. Retail pharmacies serve as convenient and reliable sources for purchasing healthcare supplies, including cancer diagnostic kits. Moreover, the presence of knowledgeable pharmacists in retail pharmacies enhances customer guidance on the proper use of testing kits. However, it is anticipated that the online pharmacy category will witness the fastest growth in the coming years. The increasing popularity of e-commerce and the convenience of online purchasing have propelled the rise of online pharmacies. These platforms offer doorstep delivery and a diverse range of healthcare supplies, including at-home cancer testing kits. The surge in online pharmacy usage has been accelerated by the COVID-19 pandemic, with individuals opting to avoid traditional pharmacies and engage in social isolation.

Global At-Home Cancer Testing Kits Market Segmentation: By Region

• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

The North American region is expected to dominate the global at-home cancer testing kits market, primarily due to the high prevalence of cancer, extensive use of advanced technologies in cancer detection and management, and the presence of major players and manufacturers. Following North America, Europe is anticipated to hold a significant market share, driven by increasing awareness and demand for at-home cancer testing kits, as well as the presence of key players in the region. The Asia-Pacific region is projected to exhibit the fastest growth rate in the global at-home cancer testing kits market, propelled by rising cancer incidence, growing disposable income, and increasing healthcare expenditures in the region.

Key Players:

• Lepu Medical Technology Co., Ltd.
• ulti med Products GmbH
• Laboratory Corporation of America Holdings
• ELITech Group SAS
• GY Highland Biotech LLC
• Exact Sciences Corp.
• Everlywell, Inc.
• Abingdon Health Quidel Corporation
• Pinnacle Biolabs
• iDNA